PPT-Clinical Presentation of Type 2 Diabetes 1 Age ≥45 years Family history of T2D or cardiovascular

Clinical Presentation of Type 2 Diabetes 1 Age 45 years Family history of T2D or cardiovascular disease Overweight or obese Sedentary lifestyle NonCaucasian ancestry Previously identified IGT IFG andor metabolic syndrome. Tyrell Hardtke. Diabetes in the Family: A Case Study. CDC’s 2005 Science Ambassador Program. Today’s Question: . . You learn that type 2 diabetes “runs in the family.” . How can you avoid developing type 2 diabetes?. Applying evidence based medicine to clinical care. Cardiovascular disease is the biggest killer in UK. Number. of . deaths. (000’s). 124,037. 60,666. 18,165. 33,634. 16,216. 12,762. 103,431. 19,996. 1. Risk Factors for Prediabetes and Type 2 Diabetes. Family history of diabetes mellitus. Cardiovascular disease. Being overweight or obese. Sedentary lifestyle. Nonwhite ancestry. Previously identified impaired glucose tolerance, impaired fasting glucose, and/or metabolic syndrome. Objectives. Diabetes overview. Type 1. Gestational diabetes. Type 2. Diabetes: Definition. Increased blood sugar as a result of insulin deficiency or resistance. Type 1- Autoimmune disorder. Type 2- Acquired insulin deficiency or resistance. Years from . diagnosis. 0. 5. -10. -5. 10. 15. Pre-diabetes. Onset. Diagnosis. Insulin secretion. Insulin “efficiency”. Ramlo-Halsted BA, Edelman SV. . Prim Care. . 1999;26:771-789 Nathan DM. . N Engl J Med. . Deepak L. Bhatt, MD, MPH. Professor . of Medicine, Harvard Medical School. Executive Director of Interventional Cardiovascular Programs. Brigham & Women’s Hospital Heart and Vascular Center. Boston, Massachusetts. 1. Obesity. Management of Common Comorbidities in Diabetes. 2. 3. 4. More Than Two Thirds of US Adults Are Overweight or Obese. 5. *2014 rate of overweight not reported in . Flegal. et al 2016; 2012 rate carried over based on historic stability of overweight prevalence.. Aspirin in Primary Prevention, GLP-1 Agonists, Metformin, Psychotropic Drug Monitoring. Nathan Bertsch, PharmD. Mitchell Elting, MD. Most patients should not take aspirin for primary prevention of cardiovascular disease. European Association for the Study of Diabetes. Lisbon, . 13. th. . September 2017. ISRCTN number: 91899513. ClinicalTrials.gov number: . NCT00829660. Study Rationale, Design and Conduct. The Diabetes Burden. history and reality.. dr.Hery. . Emria.SpPD. -KGH. BAGIAN. /SMF. ILMU PENYAKIT DALAM. . RS. PUSAT PERTAMINA. . JAKARTA. 2020. People with Diabetes and CV Disease Die Earlier . 2018 ADA GUIDELINES. Dr. . Sanjana. Bhagwat. Moderator : Dr. S. . Jotkar. Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy. Farzad. . Hadaegh. , MD, . Professor of Internal Medicine & Endocrinology. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences. Shahid. . Beheshti. University of Medical Sciences . GGC MCN meeting 5. th. February 2019. John R Petrie. Professor of Diabetic Medicine. University of Glasgow, UK. Advisory and Consultancy Work:. Novo Nordisk, Sanofi-Aventis, Biocon, Astra Zeneca, . Servier.